JP Stock MarketDetailed Quotes

4519 Chugai Pharmaceutical

Watchlist
  • 6720.0
  • -112.0-1.64%
20min DelayMarket Closed Sep 13 15:00 JST
11.28TMarket Cap33.97P/E (Static)

Chugai Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chugai Pharmaceutical Q2 2024 Earnings Date

Currency：JPYJul 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
315.91B
--
+18.13%
EPS
--
33.99
--
+34.43%
Analyst Rating
Buy

Sep 5, 2024

Chugai Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 291.455B--
Oct 25, 20242024/Q3-- / 274.305B--
Jul 25, 20242024/Q2315.911B / 276.349B--
Apr 24, 20242024/Q1236.900B / 242.461B--
Feb 1, 20242023/Q4273.812B / 292.342B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 291.455B--
Oct 25, 20242024/Q3-- / 274.305B--
Jul 25, 20242024/Q2315.911B / 276.349B--
Apr 24, 20242024/Q1236.900B / 242.461B--
Feb 1, 20242023/Q4273.812B / 292.342B--

Unlock Free Earnings Estimates

Chugai Pharmaceutical Earnings Reports

  • Chugai Pharmaceutical: Confirmatory letter.

    Jul 26 02:02 ET

  • Chugai Pharmaceutical: Interim report - 114th Period (01/01/2024 - 12/31/2024)

    Jul 26 02:01 ET

  • Chugai Pharmaceutical: Confirmation letter

    Jul 26 01:35 ET

  • Chugai Pharmaceutical: (Correction/Correction of numerical data) Correction of some parts of the "Fiscal Year ending December 2023 Consolidated Financial Statements [IFRS] (Consolidated)"

    Jul 26 01:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 5, 2024

    Buy

    • Strong Buy

      40.00%

    • Buy

      13.33%

    • Hold

      40.00%

    • Underperform

      6.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data